The Europe joint pain injections market is anticipated to record a CAGR of 8.30% during the estimated years of 2022 to 2030. The market growth of the region is determined by key factors such as the increasing incidence of orthopedic diseases, the rising pharmaceutical production, growing innovations by biopharmaceutical companies, and developments in manufacturing facilities and industries.
EUROPE JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030
Europe Market by Joint Type (Knee, Shoulder and Elbow, Hip, Foot and Ankle, Other Joint Types) Market by Injection Type (Hyaluronic Acid, Corticosteroid, Other Drugs) Market by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels) by Geography
The Europe joint pain injections market is anticipated to record a CAGR of 8.30% during the estimated years of 2022 to 2030. The market growth of the region is determined by key factors such as the increasing incidence of orthopedic diseases, the rising pharmaceutical production, growing innovations by biopharmaceutical companies, and developments in manufacturing facilities and industries.
To learn more about this report, request a free sample copy
The Europe joint pain injections market growth evaluation comprises the assessment of the United Kingdom, Russia, Spain, Italy, Germany, France, Nordic Countries, and Rest of Europe. The United Kingdom’s joint pain injections market is predominantly fueled by government support. The government’s investments have significantly driven productivity, facilitating sustainable innovation funds to augment the country’s pharmaceutical industry. In this regard, companies like Eli Lilly, AstraZeneca, and GSK have substantially contributed to the United Kingdom’s pharmaceuticals, in addition to leading extensive research and development.
On the other hand, the surging incidence of joint pain plays a vital role in propelling the market growth in France. According to the survey by Inserm as well as ‘Ensemble Contre les Rhumatismes,’ termed ‘Les Français et les Rhumatismes’ (Rheumatic Diseases and the French), nearly 93% of individuals living in the country have joint pain. The report also asserts that 12-13 million citizens were diagnosed with rheumatic conditions, including osteoarthritis, chronic inflammatory rheumatic diseases, and idiopathic juvenile arthritis. Therefore, these factors are set to proliferate the Europe joint pain injections market growth over the forecast years.
Ferring Pharmaceuticals, headquartered in Switzerland, is a biopharmaceutical company involved in the distribution and development of products associated with musculoskeletal health, women’s health, urology, and gastroenterology. In addition to the diverse range of products within the operating segments, it also comprises a robust product pipeline for multiple health indications. Moreover, the company has 12 research and development centers situated in the United Kingdom, the United States, Russia, and others.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- PARENT MARKET ANALYSIS: ORTHOPEDIC PROCEDURES MARKET
- KEY DRIVERS
- BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
- GROWING NUMBER OF SPORT INJURIES
- PREVALENCE OF MUSCULOSKELETAL DISORDERS
- KEY RESTRAINTS
- HIGH COSTS OF JOINT REPAIR THERAPIES
- SIDE EFFECTS ASSOCIATED WITH JOINT REPAIR INJECTIONS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON JOINT PAIN INJECTIONS MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRY
- INDUSTRY RIVALRY
- KEY BUYING CRITERIA
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY JOINT TYPE
- KNEE
- SHOULDER AND ELBOW
- HIP
- FOOT AND ANKLE
- OTHER JOINT TYPES
- MARKET BY INJECTION TYPE
- HYALURONIC ACID
- CORTICOSTEROID
- OTHER DRUGS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITALS PHARMACIES
- RETAIL PHARMACIES
- OTHER DISTRIBUTION CHANNELS
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- GERMANY
- FRANCE
- UNITED KINGDOM
- ITALY
- SPAIN
- NORDIC COUNTRIES
- RUSSIA
- REST OF EUROPE
- EUROPE
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
- ALLERGAN PLC (ACQUIRED BY ABBVIE)
- ANIKA THERAPEUTICS INC
- BIOVENTUS INC
- CHUGAI PHARMACEUTICAL
- FERRING PHARMACEUTICALS
- FIDIA PHARMA USA INC
- FLEXION THERAPEUTICS INC
- ORTHOGENRX INC
- PFIZER INC
- SANOFI
- SEIKAGAKU CORPORATION
- SMITH & NEPHEW PLC
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- ZIMMER BIOMET HOLDINGS
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – JOINT PAIN INJECTIONS
TABLE 2: EUROPE JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: EUROPE JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 4: EUROPE JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: EUROPE JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: EUROPE JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: EUROPE JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: EUROPE JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: EUROPE JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: LEADING PLAYERS OPERATING IN EUROPE JOINT PAIN INJECTIONS MARKET
TABLE 11: LIST OF MERGERS & ACQUISITIONS
TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: EUROPE JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, IN 2021
FIGURE 6: EUROPE JOINT PAIN INJECTIONS MARKET, BY KNEE, 2022-2030 (IN $ MILLION)
FIGURE 7: EUROPE JOINT PAIN INJECTIONS MARKET, BY SHOULDER AND ELBOW, 2022-2030 (IN $ MILLION)
FIGURE 8: EUROPE JOINT PAIN INJECTIONS MARKET, BY HIP, 2022-2030 (IN $ MILLION)
FIGURE 9: EUROPE JOINT PAIN INJECTIONS MARKET, BY FOOT AND ANKLE, 2022-2030 (IN $ MILLION)
FIGURE 10: EUROPE JOINT PAIN INJECTIONS MARKET, BY OTHER JOINT TYPES, 2022-2030 (IN $ MILLION)
FIGURE 11: EUROPE JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, IN 2021
FIGURE 12: EUROPE JOINT PAIN INJECTIONS MARKET, BY HYALURONIC ACID, 2022-2030 (IN $ MILLION)
FIGURE 13: EUROPE JOINT PAIN INJECTIONS MARKET, BY CORTICOSTEROID, 2022-2030 (IN $ MILLION)
FIGURE 14: EUROPE JOINT PAIN INJECTIONS MARKET, BY OTHER DRUGS, 2022-2030 (IN $ MILLION)
FIGURE 15: EUROPE JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, IN 2021
FIGURE 16: EUROPE JOINT PAIN INJECTIONS MARKET, BY HOSPITALS PHARMACIES, 2022-2030 (IN $ MILLION)
FIGURE 17: EUROPE JOINT PAIN INJECTIONS MARKET, BY RETAIL PHARMACIES, 2022-2030 (IN $ MILLION)
FIGURE 18: EUROPE JOINT PAIN INJECTIONS MARKET, BY OTHER DISTRIBUTION CHANNELS, 2022-2030 (IN $ MILLION)
FIGURE 19: EUROPE JOINT PAIN INJECTIONS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 20: GERMANY JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 21: FRANCE JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 22: UNITED KINGDOM JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 23: ITALY JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 24: SPAIN JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 25: NORDIC COUNTRIES JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 26: RUSSIA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 27: REST OF EUROPE JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- GERMANY
- FRANCE
- UNITED KINGDOM
- ITALY
- SPAIN
- NORDIC COUNTRIES
- RUSSIA
- REST OF EUROPE
- EUROPE
- MARKET BY JOINT TYPE
- KNEE
- SHOULDER AND ELBOW
- HIP
- FOOT AND ANKLE
- OTHER JOINT TYPES
- MARKET BY INJECTION TYPE
- HYALURONIC ACID
- CORTICOSTEROID
- OTHER DRUGS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITALS PHARMACIES
- RETAIL PHARMACIES
- OTHER DISTRIBUTION CHANNELS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.